N/A N=64 Randomized Single-blind Supportive Care

Mind-body Resiliency Intervention for Fear of Cancer Recurrence

Cancer · Coping Skills · Coping Behavior

Bottom Line

View on ClinicalTrials.gov: NCT04876599 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2023

Primary outcome: Primary: Feasibility: Retention Rate — 31; 31 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: IN FOCUS (Behavioral); Usual Care (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Massachusetts General Hospital
Primary completion: Aug 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility: Retention Rate	31; 31	—
PRIMARY Acceptability: 5 Item Measure of Enjoyableness, Convenience, Helpfulness, Odds of Future Use, and Overall Satisfaction	4.33; 4.57; 4.00; 4.33; 4.20	—
SECONDARY Fear of Cancer Recurrence	23.62; 22.22; 19.74; 20.90; 20.66; 19.27	—
SECONDARY Resiliency	71.05; 75.23; 76.24; 76.80; 81.05; 75.45	—

Summary

The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.

Eligibility Criteria

Inclusion Criteria

History of non-metastatic, localized, or regional solid or blood malignancy(ies)
Completion of primary cancer treatment (i.e., radiation, surgery, chemotherapy) and/or current use of long-term maintenance hormonal or biologic therapy
Age ≥18 years
Elevated fear of recurrence (FCRI severity score ≥16)
MGB/BIDMC Medical Record Number (MRN)

Exclusion Criteria

Self-reported inability to speak and write in English
Undertreated serious mental illness as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year
Inability to access technology and/or sufficient internet to participate virtual groups sessions

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04876599). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.